XClose

Early Phase Cancer Trials Programme at UCL and UCLH

Home
Menu

Hepatobiliary Trials

A LIST OF OUR EARLY PHASE Hepatobiliary TRIALS WHICH ARE OPEN TO RECRUITMENT AT UNIVERSITY COLLEGE LONDON HOSPITALS

To find more information on UCLH Early Phase Cancer Clinical Trials, including eligibility criteria, click the hyperlinked Local Project Reference (LRP) ID, which will take you to the UCLH Find a Study database.

Additional early phase clinical trials recruiting Hepatobiliary cohorts may be found in the Advanced Solid Tumour Trials Portfolio page.

RLY-4008-101

A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With Intrahepatic Cholangiocarcinoma (ICC) and Other Advanced Solid Tumors

Local Project Reference:141772
Principal Investigator:Prof. John Bridgewater
Drug Class/ Treatment:RLY-4008 (FGFR2 Inhibitor)
Patient Population:

Intrahepatic Cholangiocarcinoma (ICC) with FGFR2 Fusion

Unresectable or Metastatic Solid Tumours with FGFR2 Fusion, Amplification or Mutation

Trial Hosted By - NIHR UCLH Clinical Research Facility (CRF)